VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation

TVM Capital Life Science announces promotions to recognize significant contributions of up-and-coming leaders

ONWARD receives new FDA Breakthrough Device Designations for bladder control, alleviation of spasticity, and blood pressure regulation after spinal cord injury

Abivax publishes a prospectus in the context of its capital increase

iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer

Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European Biotech investors

Esperas Pharma, Inc. announces investment from TVM Life Science Innovation I and the Fonds de solidarité FTQ

Mainz Biomed acquires entire intellectual property portfolio for its colorectal cancer diagnostic test program

Leading fashion company joins fiber-to-fiber consortium founded by Carbios, On, Patagonia, PUMA and Salomon

Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer